GlaxoSmithKline (GSK), Theravance (THRX) Announce Relvar/Breo Ellipta SUMMIT COPD Study Missed Primary Endpoint
Tweet Send to a Friend
GlaxoSmithKline (NYSE: GSK) and Theravance, Inc. (NASDAQ: THRX) announced initial results from the Study to Understand Mortality and MorbidITy in ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
